What CareLumi's CVO Platform Verified and Built
Select a category, then any item to see what the platform confirms.
Primary source verification (PSV) confirms every credential directly with the issuing body, not from self-reported data. Each verification report is built to the standard required for hospital privileging submissions.
Customer Overview
Frado.Ai is an AI-enabled pathology company that routes contracted pathologists to hospital systems for remote slide reads. Frado Healthcare LLC is Frado.Ai's affiliated independent clinical laboratory entity, formed to enable pathologist reads to be billed directly through the lab. Both companies are led by Surya Pal Chahar, CEO, and both were brand-new at the time of engagement, with no credentialing history of any kind.
The Challenge
When Surya Chahar engaged CareLumi in early April 2026, neither entity had any credentialing infrastructure. There were no verified provider files, no payer enrollments, no DataSpring (formerly CAQH, the Council for Affordable Quality Healthcare, which maintains a centralized database used by payers to collect and store provider credentialing data) profiles, no federal exclusion monitoring, and no internal process for managing any of it.
The consequences were immediate and structurally linked. Without PSV reports, hospital administrators cannot grant privileging (the process by which a healthcare organization formally authorizes a provider to perform specific clinical procedures based on verified training and competency). Without privileging, Frado.Ai's pathologists could not be placed and could not generate revenue.
On the facility side, Frado Healthcare LLC could not bill Medicare or MO HealthNet without enrollment. The sequence was also legally mandatory: MO HealthNet's Type 70 enrollment cannot be submitted until a Medicare Provider Transaction Access Number (PTAN) is issued, meaning every upstream delay compounds the timeline directly.
Surya evaluated traditional credentialing organizations before CareLumi, including one offshore firm and several U.S.-based companies. The alternatives quoted approximately five weeks for verification reports alone. As a startup CEO managing a lean team with no dedicated credentialing staff, Surya needed a partner who already knew what needed to be done and could move fast without requiring him to manage the process.
Why They Chose CareLumi
Frado's business model requires onboarding a large number of pathologists across multiple hospital clients, each operating under different privileging standards and insurance requirements. Surya needed a partner capable of handling both provider verification and facility enrollment under one engagement, at the scale Frado's pipeline demands.
CareLumi's turnaround, significantly faster than every alternative Surya evaluated, was the decisive factor. The ability to run both workstreams simultaneously under a single platform fit the operational reality of a startup that could not absorb the overhead of managing multiple credentialing relationships. Surya noted that engaging CareLumi also meant Frado did not need to hire a dedicated in-house credentialing resource, eliminating both the direct cost and the onboarding time that hire would have required.
Implementation
CareLumi launched two parallel workstreams on the day the contract was signed, with both tracks active from engagement initiation.
Frado.Ai: Pathologist Verification
CareLumi built the full intake infrastructure from scratch, including provider intake forms using a single-use, 72-hour magic link (so pathologists never need to log into a portal), a PSV tracker, and a DataSpring onboarding workflow. The Pathologist Verification Standard Operating Procedure version 1.1 was issued in the weeks following engagement start.
A growing pipeline of pathologists completed intake and received uploaded verification reports. Each report covered state licenses, board certifications, Drug Enforcement Administration (DEA) registration, Educational Commission for Foreign Medical Graduates (ECFMG) status where applicable, post-graduate training, and malpractice history, all verified against primary sources.
Federal exclusion monitoring is now live on a 30-day cycle for all providers, covering the Office of Inspector General (OIG) List of Excluded Individuals and Entities (LEIE), System for Award Management (SAM.gov), Office of Foreign Assets Control (OFAC), the Centers for Medicare and Medicaid Services (CMS, the federal agency that administers Medicare and Medicaid payment policy) Preclusion List, Medicare Order and Referring file, CMS Opt-Out, and state Medicaid exclusion lists per licensed state per provider.
Frado Healthcare LLC: Facility Enrollment
CareLumi executed a six-phase build for the Medicare enrollment process. Phase 0 locked the canonical entity identity, assembling the core document package from state registration records, IRS entity confirmation, the Clinical Laboratory Improvement Amendments (CLIA, the federal regulatory framework governing laboratory testing quality standards) certificate, and Commission on Office Laboratory Accreditation (COLA, the accrediting body for independent clinical laboratories) correspondence.
Phase 1 covered COLA accreditation and lab director verification, including a full re-credentialing (the periodic process by which providers renew their verified credentials with payers and health systems) cycle following a lab director transition. Phase 2 locked all organizational data for submissions and confirmed bank verification. Phase 3 secured the Type 2 National Provider Identifier (NPI) in the National Plan and Provider Enumeration System (NPPES). Phase 4 built the Centers for Medicare and Medicaid Services 855B form (CMS-855B, the facility enrollment application required for independent clinical laboratories to participate in Medicare). Phase 5 covers the MO HealthNet application, pending Phase 4 completion. Phase 6 covers post-enrollment compliance.
Two Parallel Workstreams, One Engagement
Select any phase to see what the platform executed. Dashed phases are pending external approvals outside CareLumi's control.
Multiple compliance obstacles were identified and resolved across the engagement, with no CEO involvement required in remediation. These included a facility address discrepancy across regulatory documents, a lab director transition requiring a full primary source verification cycle to federal standards, a CLIA certificate type issue resolved through the COLA accreditation process, a National Practitioner Data Bank (NPDB) peer review document rejection resolved by drafting a standalone document to the 45 CFR 60.3 standard, and a missing baseline enrollment history resolved through a formal Provider Enrollment, Chain and Ownership System (PECOS) negative search.
By the time the engagement reached its completion phase, the Type 2 NPI was confirmed in NPPES, documentation was uploaded and organized across all required categories in the CareLumi Credentials Verification Organization (CVO, a platform or body that manages the full credentialing and compliance lifecycle for healthcare providers) platform, and the CMS-855B packet was substantially complete. Submission is pending two external approvals outside any credentialing vendor's control: the CLIA Certificate of Accreditation, awaiting CMS issuance following COLA survey completion, and CMS Identity and Access Management surrogate approval.
Results and Business Impact
From Zero to Credentialing-Ready
Toggle between engagement start and today.
Pathologist pipeline built from zero. Before CareLumi, Frado.Ai had no verified provider files of any kind. The CareLumi CVO platform built the full intake and verification workflow, and 15+ pathologists are now credentialing-ready for hospital privileging submissions.
Facility enrollment packet complete, roughly three times faster than industry norms.The industry benchmark for independent lab credentialing from scratch is 6 to 9 months. CareLumi's platform-facilitated workflow completed the CMS-855B packet substantially ahead of the 6-to-9-month industry benchmark, with submission pending only external regulatory approvals outside any credentialing vendor's control.
Multiple compliance obstacles identified and resolved without CEO involvement. Every blocker that arose during the engagement was identified and resolved by the CareLumi CVO platform and operations team (from a lab director transition requiring full re-verification to an NPDB document rejection requiring a new draft built to federal standards). None required Surya to manage the remediation directly.
No dedicated credentialing hire needed. Surya estimated that without CareLumi, Frado would have needed to bring on an in-house credentialing resource and absorb onboarding time, a material cost for a lean startup. The CareLumi engagement eliminated that need entirely.
Continuous compliance coverage from day one. Monthly OIG and SAM.gov exclusion monitoring is active for Frado Healthcare LLC and its key organizational parties, all confirmed clear as of July 2026. Thirty-day federal exclusion monitoring is live for all pathologists in the Frado.Ai pipeline, with no flags identified to date.
In Their Words
“CareLumi made it possible for Frado.Ai to operate in the first place. Without CareLumi, Frado.Ai would not have had the verification reports it needs to function. On the facility enrollment for Frado Healthcare LLC, CareLumi already knew what needed to be done and handled it, instead of my team having to build the process from scratch.”
“Frado.Ai is a startup, and most pathology companies like it are run by CEOs who are themselves practicing pathologists with limited time. Having a partner handle the credentialing and verification work, without requiring much of my own time, is what makes CareLumi useful to a company like mine.”